Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) has received an average recommendation of “Moderate Buy” from the ten brokerages that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is $162.25.
Several equities research analysts have commented on the stock. Northland Securities lowered their target price on shares of Axon Enterprise from $180.00 to $130.00 in a research note on Thursday, May 12th. JMP Securities reissued a “buy” rating and set a $195.00 price objective on shares of Axon Enterprise in a research report on Wednesday, June 1st. Robert W. Baird lowered their price objective on shares of Axon Enterprise from $145.00 to $125.00 in a research report on Wednesday, May 11th. Credit Suisse Group lowered their price objective on shares of Axon Enterprise from $169.00 to $134.00 in a research report on Thursday, July 14th. Finally, Morgan Stanley downgraded shares of Axon Enterprise from an “overweight” rating to an “equal weight” rating and set a $120.00 price objective for the company. in a research report on Monday, May 23rd.
Insider Buying and Selling at Axon Enterprise
In related news, Director Mark W. Kroll sold 3,159 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, June 8th. The shares were sold at an average price of $102.82, for a total transaction of $324,808.38. Following the sale, the director now directly owns 13,691 shares of the company’s stock, valued at approximately $1,407,708.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 6.90% of the company’s stock.
Institutional Investors Weigh In On Axon Enterprise
Ad Investing Daily
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!
When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Several hedge funds have recently added to or reduced their stakes in AXON. Prospera Financial Services Inc acquired a new position in shares of Axon Enterprise in the 1st quarter worth approximately $27,000. Trust Co. of Vermont acquired a new position in shares of Axon Enterprise during the 2nd quarter valued at $28,000. Retirement Planning Co of New England Inc. acquired a new position in shares of Axon Enterprise during the 4th quarter valued at $31,000. Sandy Spring Bank lifted its position in shares of Axon Enterprise by 230.0% during the 2nd quarter. Sandy Spring Bank now owns 330 shares of the biotechnology company’s stock valued at $31,000 after acquiring an additional 230 shares during the period. Finally, Tyler Stone Wealth Management acquired a new position in shares of Axon Enterprise during the 4th quarter valued at $32,000. 72.06% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Price Performance
Shares of Axon Enterprise stock opened at $116.23 on Tuesday. Axon Enterprise has a 1-year low of $82.49 and a 1-year high of $209.00. The firm’s 50-day moving average price is $96.81 and its two-hundred day moving average price is $112.82. The stock has a market capitalization of $8.25 billion, a price-to-earnings ratio of 223.52 and a beta of 0.66. The company has a current ratio of 2.43, a quick ratio of 2.18 and a debt-to-equity ratio of 0.02.
Axon Enterprise (NASDAQ:AXON – Get Rating) last announced its earnings results on Tuesday, May 10th. The biotechnology company reported $0.76 earnings per share (EPS) for the quarter. Axon Enterprise had a net margin of 4.62% and a return on equity of 3.90%. The company had revenue of $256.43 million for the quarter, compared to analyst estimates of $233.57 million. During the same period in the prior year, the business earned ($0.75) earnings per share. Axon Enterprise’s quarterly revenue was up 31.5% on a year-over-year basis. On average, equities analysts predict that Axon Enterprise will post 1.35 earnings per share for the current fiscal year.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Read More: Axon Enterprise, Inc. (NASDAQ:AXON) Receives Average Recommendation of “Moderate Buy”